Evox Therapeutics

Evox Therapeutics is a forward-thinking biomedical establishment with a central focus on the development of transformative exosome therapeutics. Emanating its ground-breaking solutions from Oxford Science Park, England, this platform-driven company was set up with a primary aim to address serious, life-threatening rare diseases for which current treatment options are limited. With a motto of being 'Naturally inspired, Engineered to deliver', Evox Therapeutics blends biological inspiration with advanced science to create and deliver innovative therapies.

With its proprietary DeliverEX™ platform at its core, Evox Therapeutics is making significant strides in the field of exosome-based therapeutics. An integral part of the company's workings, the DeliverEX™ platform, provides highly versatile delivery capabilities. This is combined with impressive targeting technology and sophisticated biomolecular engineering approaches in order to advance their quest of countering life-threatening rare diseases. The company not only focuses on internal developments but also seeks to form partnerships that can leverage the power of their DeliverEX™ platform, thereby extending the reach and impact of their innovative solutions.

Evox Therapeutics is constantly refining and improving its approaches, as evidenced by the companies recently released Landmark paper in Nature Communications which highlights advancements in their proprietary exosome engineering platform. Furthermore, the firm has demonstrated versatility through developing next-generation exosome-delivered AAV gene therapy for heart disease treatment, as well as acquiring Exosome AAV Technology and Intellectual Property. As such, Evox Therapeutics is shaping up as an industry leader in providing life-saving treatments to diseases that have, until now, proven difficult to manage. Therefore, whether as a potential investor, partner, or beneficiary of their developed treatments, Evox Therapeutics is a company worth paying close attention to.

Connect